Navigation Links
Survey of More than 600 Patients Treated with Tracleer(R) (bosentan) Reveals Actelion Sure Steps(R) Patient Support Program Provides Valuable Educational Information
Date:12/18/2007

wo significant safety concerns: potential for serious liver injury (including rare cases of liver failure and unexplained hepatic cirrhosis in a setting of close monitoring) and high potential for major birth defects. Liver monitoring of all patients is essential prior to initiation of treatment and monthly thereafter. Pregnancy must be excluded and prevented by two forms of birth control; monthly pregnancy tests should be obtained. Because of these risks, Tracleer is only supplied through a controlled distribution system, the Tracleer Access Program (T.A.P.(R))

About Ventavis(R)

Ventavis(R) (iloprost) is an inhaled formulation of iloprost, a synthetic compound that is structurally similar to prostacyclins -- naturally occurring molecules that cause blood vessels to dilate. Ventavis is indicated for the treatment of pulmonary arterial hypertension (WHO Group I) in patients with New York Heart Association (NYHA) Functional Class III or IV. In controlled trials, Ventavis improved a composite endpoint consisting of exercise tolerance, symptoms (NYHA Class), and lack of deterioration.

In clinical studies, common adverse reactions due to Ventavis included vasodilation (flushing), cough, headache, trismus, and insomnia. Serious adverse events reported at a rate of less than 3% included congestive heart failure, chest pain, supraventricular tachycardia, dyspnea, peripheral edema, and kidney failure. Vital signs should be monitored while initiating Ventavis. Ventavis should not be initiated in patients with systolic blood pressure less than 85 mm Hg. Stop Ventavis immediately if signs of pulmonary edema occur; this may be a sign of pulmonary venous hypertension.

About Actelion Pharmaceuticals

Actelion Pharmaceuticals has pioneered research and development in the pulmonary arterial hypertension (PAH) disease area. More than 40,000 PAH patients have been prescribed Actelion's product Tracleer, an orally available dual endothelin receptor ant
'/>"/>

SOURCE Actelion Pharmaceuticals US, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. New Survey Reveals Many Adults With High Cholesterol Fail to Take Necessary Steps to Improve Their Condition
2. International Survey Shows People Over Forty Ignore Risk of Blindness
3. 2007 Global Survey Identifies Characteristics of Supply Chain Leaders
4. Survey Sees Mass. CEOs as Bullish on Own Businesses
5. Boehringer Ingelheim Receives Top Honor as Worlds Most Respected Biopharmaceutical Employer in Science 2007 Top Employers Survey
6. Video: New Survey Finds Technology Plays a Critical Role in Lives of People with Multiple Sclerosis, Yet Many Are Not Using it to Overcome Disease-Related Challenges
7. National Survey Shows Most Women Are Not Satisfied With Their Progesterone Treatment
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)..., MOUNTAIN VIEW, Calif. Nov. 5, 2009 Complet...cing company, today announced publication of a rep...etary DNA sequencing platform, including analysis .... The consumables cost for these three genomes seq...rrays ranged from $8,005 for 87x coverage to $1,72...
(Date:11/6/2009)..., AURORA, Ontario, Nov. 6 /PRNewswire-FirstCall/ ...heets: HXBPF) today announced that John Docherty, ...t at Merriman Curhan Ford,s 6th annual Investor Su...l Hotel in New York City. Mr. Docherty will provi...velopment programs L-DOS47 and Topical Interferon ...
(Date:11/6/2009)..., SPRING VALLEY, Calif., Nov. 6 C...warded a Small Business Innovative Research (SBIR)...h and Material command. Under terms of the agreeme...nts (ASRs) for the diagnosis of Dengue virus. ,...at represents a major threat to military forces de...
(Date:11/5/2009)... TRANSPORTATION -- Gone hybrid . . . , Fuel e...iles are now posted at the www.fueleconomy.gov w...oped and maintains for the U.S. Department of Ener...ine of the top 10 vehicles on the best fuel econom...us (51 MPG city; 48 highway). "This list proves th...
Breaking Biology Technology:Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3
...November 6 deCODE genetics,(Nasdaq: DCGN ) today...the,quarter ended September 30, 2008. A conference...rating highlights and a strategic update will,be w...m EST/1pm GMT,(details below)., Operating loss fo...ed,to $22.2 million for the third quarter 2007. Op...
...t to host call and webcast today at 5:00 p.m. East...ent business highlights -, SAN DIEGO, Calif., Nov... ), a biopharmaceutical company focused on,the tre...-related,disorders, today announced unaudited fina...September 30, 2008., Three Months Ended September...
...call scheduled for November 6, 2008 at 1:30 p.m. (... at http://www.adventrx.com , SAN DIEGO, Nov. 6 ...opharmaceutical company focused on in-licensing,de...andidates primarily for,the treatment of cancer, t...h and nine-month periods ended September 30, 2008....
Other Biology Technology:deCODE genetics Announces Third Quarter 2008 Financial Results 2deCODE genetics Announces Third Quarter 2008 Financial Results 3deCODE genetics Announces Third Quarter 2008 Financial Results 4deCODE genetics Announces Third Quarter 2008 Financial Results 5deCODE genetics Announces Third Quarter 2008 Financial Results 6deCODE genetics Announces Third Quarter 2008 Financial Results 7deCODE genetics Announces Third Quarter 2008 Financial Results 8deCODE genetics Announces Third Quarter 2008 Financial Results 9deCODE genetics Announces Third Quarter 2008 Financial Results 10deCODE genetics Announces Third Quarter 2008 Financial Results 11deCODE genetics Announces Third Quarter 2008 Financial Results 12Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 2Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 3Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 4Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 5Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 6Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 7Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 8Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results 9ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update 2ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update 3ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update 4ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update 5ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update 6ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update 7ADVENTRX Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update 8
(Date:11/9/2009)...pid, mysterious death of phytoplankton in the Nort...cientists at Rutgers University and the Woods Hole...ical may hold unexpected promise in cancer researc...pid, or fatty compound, in a virus that has been a...lankton that plays a major role in the global carb...
(Date:11/8/2009)...TH INTELLECTUAL DISABILITIES: AN OPPORTUNITY FOR H...volving adults with intellectual disabilities foun...knowledge after taking a semi-weekly class for fou...ccepted term for mental retardation, have slightly...preventable chronic diseases compared to the gener...
(Date:11/6/2009)...l Center and the Chinese Academy of Sciences (CAS)... on Taste and Smell Research. Organized by Monell ... the first international meeting on taste and smel...cutive Officer, American Association for the Advan...ce magazine, will open the meeting with a plenary ...
Breaking Biology News(10 mins):Newly discovered fat molecule: An undersea killer with an upside 2Newly discovered fat molecule: An undersea killer with an upside 3Newly discovered fat molecule: An undersea killer with an upside 4Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Monell Center joins with CAS to host Beijing meeting on taste and smell research 2 248 million NIH grant for heart cell development and study 59898 1 248 million NIH grant for heart cell development and study 59898 2Growing cartilage from stem cells 10456 1Prolonged Use of Pacifier Linked to Speech Problems 59896 1
... prediction program by computer scientists at Wash...sts to predict the very beginnings of gene transcr...rs thereby defining the first exon of the gene. , ...WINSCAN is called N-SCAN. Michael Brent, Ph.D. pro...y in St. Louis, together with Samuel S. Gross, the...
...sults more accurate than PSA , Researchers at the...r have identified a panel of 22 biomarkers that to...ate cancer than the current prostate specific anti.... 22 issue of the New England Journal of Medicine.... 331 prostate cancer patients prior to surgery, an...
...or its therapeutic effect on burned or irritated s... as a healthful additive to your fruits and veggie...gel from the tropical plant that can be used as an...of fresh produce. The gel, which does not appear t...s a safe, natural and environmentally-friendly alt...
Other Biology News:Modification of program enables prediction of gene transcription 2Modification of program enables prediction of gene transcription 3U-M researchers identify new blood test for prostate cancer 2U-M researchers identify new blood test for prostate cancer 3Aloe vera coating may prolong freshness, safety of fruits and vegetables 2
MHC Volumes 1 & 2 from Promega
Custom Production Service from AbD Serotec
MitoScreen (JC-1) Kit from BD Biosciences Pharmingen
Single-stranded carrier DNA, 3 x 1 ml from Dualsystems Biotech AG
Biology Products: